As a passionate literacy advocate, he is taking a leading role in addressing the literacy gap across Illinois, championing initiatives that encourage reading and education for children. "Someone has ...

Saviynt, a leading provider of cloud-native identity and governance platform solutions, today announced select financial and operating results, including Q3, with record revenues and a high contracted ...

Alvotech and Advanz Pharma have submitted a European marketing application for their golimumab biosimilar to treat ...

Are you forgetting quite often? A brisk walk, dance, or climbing a few flights of stairs may be key to boosting your memory, ...

Celltrion today announced that Health Canada has approved Omlyclo™, a biosimilar referencing Xolair®. Omlyclo™ is approved ...

South Korea's pharmaceutical giant Celltrion on Monday said that it has received approval from Canadian health authorities for a biosimilar treatment for allergic asthma.

South Korean biopharmaceutical firm Celltrion said Monday that it has received approval from Health Canada for Omlyclo, its omalizumab biosimilar referencing Xolair, designed to treat allergic asthma ...

The global biosimilar monoclonal antibody market revenue was around US$ 10.6 billion in 2023 and is estimated to reach US$ 64.7 billion by 2032, growing at a compound annual growth rate (CAGR) of 22.2 ...

Discover five biosimilar companies creating affordable versions of blockbuster drugs and hoping to capitalize on the upcoming ...

Celltrion Inc., a major South Korean biopharmaceutical firm, said Thursday it has begun commercial operation of its third manufacturing plant in the country. The plant in Incheon, just west of Seoul, ...